NK cell activity and monocyte dysfunctions in a patient with common variable hypogammaglobulinemia

J Clin Lab Immunol. 1988 Nov;27(3):143-7.

Abstract

A 57-year-old man with a history of recurrent infections from the age of 50 was hospitalized with a diagnosis of common variable hypogammaglobulinemia (CVH). Immunological studies revealed a severe reduction of circulating immunoglobulins of all classes. Immunophenotyping of peripheral blood mononuclear cells (PBMC) with monoclonal antibodies, revealed normal values of total B and T cells with CD4/CD8 ratio sharply reduced (0.35) as compared to normal (1.6) because of an increase of CD8 and a decrease of CD4 cells. The surface expression of IL-2 receptor was normal. Natural cytotoxic and phagocytic system presented several abnormalities: a deep impairment of NK activity was found in spite of a normal number of NK cells, as ascertained by Leu 19 and B73.1 monoclonal antibodies. The defective NK activity was not restored by interferon alfa, but was normalized by recombinant IL-2. Phagocytic function, as defined by zymosan-stimulated O2- production was almost absent. The involvement of natural cytotoxic and phagocytic systems in CVH has been rarely reported; the possible causative role of a chronic viral infection (Epstein-Barr virus?) is discussed, on the base of anamnesis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal
  • B-Lymphocytes / immunology
  • Cell Line, Transformed
  • Cytotoxicity, Immunologic*
  • Dysgammaglobulinemia / immunology*
  • Humans
  • IgA Deficiency
  • IgG Deficiency
  • Immunoglobulin M / deficiency
  • Interferon Type I / pharmacology
  • Interleukin-2 / pharmacology
  • Killer Cells, Natural / immunology*
  • Leukocytes, Mononuclear / immunology*
  • Male
  • Middle Aged
  • Phagocytosis*
  • Recombinant Proteins / pharmacology
  • T-Lymphocytes, Regulatory / immunology

Substances

  • Antibodies, Monoclonal
  • Immunoglobulin M
  • Interferon Type I
  • Interleukin-2
  • Recombinant Proteins